Home > BionTech says "three doses" of vaccine neutralises Omicron variant

News
BionTech says "three doses" of vaccine neutralises Omicron variant

Description

Özlem Türeci, BionTech's Chief Medical Officer says that the coronavirus vaccine developed jointly by BioNTech and Pfizer neutralises the Omicron variant of the virus after three doses. A laboratory study by its makers found "three doses of our vaccine neutralise the Omicron variant", but warned that "two doses show significantly reduce neutralization of this new variant.". SOUNDBITE

Added on the 08/12/2021 16:10:58 - Copyright : AFPTV - First images

To customise your video :

Generic export code

More videos on the subject

EU seals deal with BioNTech/Pfizer for up to 1.8 bn extra vaccine doses: von der Leyen

The EU has concluded a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of its Covid-19 vaccine, European Commission chief Ursula von der Leyen says at a media conference in Porto, Portugal. SOUNDBITE

08/05/2021 - AFPTV - First images
Pfizer/BioNtech to supply 75 million more vaccine doses to the EU

Berlin (Germany), Feb 1 (EFE / EPA), (ARCHIVE).- The German company BioNTech announced Monday that it will supply the EU with 75 million doses of its Covid-19 vaccine in the second quarter of the year after optimizing its production process. ARCHIVE FOOTAGE OF BIONTECH HEADQUARTERS IN MAINZ AND VACCINATION CAMPAIGN IN STUTTGART, GERMANY.

01/02/2021 - EFE Inglés
First shipment of 8,000 doses of Pfizer-Biontech vaccine arrives in Ecuador

Quito, Jan 20 (EFE), (Camera: Juan Francisco Chávez) .- A first shipment of 8,000 doses of the vaccine from the Pfizer-Biontech consortium arrived in the Ecuadorian capital, within the framework of a vaccination plan that seeks to end the SARS coronavirus pandemic- CoV-2 in the country.FOOTAGE OF THE ARRIVAL OF THE FIRST SHIPMENT OF VACCINES.

21/01/2021 - EFE Inglés
EU doubles BioNTech/Pfizer vaccine pre-order to 600 million doses

European Commission President Ursula von der Leyen announces that the EU has struck a deal to double its supply of the Pfizer-BioNTech vaccine against Covid-19 to a total 600 million doses. SOUNDBITE

08/01/2021 - AFPTV - First images
Fosun Pharma, BioNTech to supply China with 100 million doses of Covid-19 vaccine

Shanghai, Jan 4 (EFE/EPA).- Fosun Pharma, a Chinese listed pharmaceutical company, and Germany's BioNTech reported in December that they would supply Mainland China with 100 million doses of a COVID-19 vaccine in 2021, after regulatory approval. In March 2020, Shanghai-based pharmaceutical company Fosun Pharma made a purchase agreement with BioNTech to buy 50 million USD worth of stock. It became a strategic partner in developing and producing the mRNA vaccine. (Camera: ALEX PLAVEVSKI).SHOT LIST: THE FOSUN PHARMA HEADQUARTERS BUILDING IN SHANGHAI, CHINA.

04/01/2021 - EFE Inglés